May 11, 2021

‫أعلنت شركة Dante Labs تعيين كل من Paul Jones، وSimon Partridge، وChristian Bourne لدعم البرامج العالمية لعلم الجينوم السكاني

انضم Paul Jones وSimon Partridge وChristian Bourne، الذين عملوا سابقًا في Illumina وGenomics England، إلى شركة Dante Labs في مقرها الجديد في كامبريدج بالمملكة المتحدة ليقودوا عرضها العالمي الرائد لعلم الجينوم السكاني

كامبريدج، المملكة المتحدة، 11 مايو 2021 (شركة GLOBE NEWSWIRE) – أعلنت شركة Dante Labs اليوم عن انضمام Paul Jones، وSimon Partridge، وChristian Bourne، إلى الفريق التنفيذي للشركة كجزء من مهمتها الهادفة إلى تمكين برامج علم الجينوم السكاني على نحو أسرع وأكثر فعالية على مستوى العالم.

قال Andrea Riposati، كبير المسؤولين التنفيذيين في شركة Dante Labs “يسعدنا أن نرحب بكل من Paul، وSimon، وChristian في فريقنا. نحن نشارك الرؤية للتوصل إلى حلول مبتكرة للتعجيل بتبني مبادرات علم الجينوم السكاني والطب الدقيق من قِبَل أنظمة الرعاية الصحية والحكومات في مختلف أنحاء العالم”.

سيقود هذا الثلاثيُ خططَ Dante Labs السريرية، والبحثية، وخطط إشراك الصناعة والتنمية الاقتصادية للبرامج الوطنية واسعة النطاق في مختلف أنحاء العالم. كان كل من Jones وPartridge وBourne في ما سبق جزءًا من فريق علم الجينوم السكاني في شركة Illumina التي تأهلت للانضمام إلى مؤشر S&P 500، وكانوا قد شاركوا في تطوير شركة Genomics England وتسريع نشاطها، التي تعد الآن البرنامج القياسي العالمي لعلم الجينوم السكاني.

انضم Paul Jones إلى شركة Dante Labs ليشغل منصب كبير مسؤولي الأعمال. وستحظى مؤسستنا بخبرة Paul التي تصل إلى 30 عامًا في علوم الحياة والتكنولوجيا والرعاية الصحية. حيث كان يشغل في الآونة الأخيرة منصب الرئيس العالمي لمشروع برامج علم الجينوم السكاني Population Genomics في شركة Illumina، حيث قاد فريقًا قام بإنشاء برامج واسعة النطاق لعلم الجينوم السكاني وتطويرها وإدارتها بفاعلية في جميع أنحاء العالم. شغل Paul سابقًا منصب المدير التنفيذي لبرنامج Genomics Enterprises في شركة Genomics England ومنصب رئيس أعمال Global Life Sciences في شركة Cisco. كما شغل مناصب عليا في IMS Health وNovartis وPwC Consulting.

انضم Simon Partridge إلى شركة Dante Labs ليشغل منصب نائب الرئيس العالمي لعمليات الأعمال. وكان قد شغل مؤخرًا منصب رئيس تطوير السوق العالمية Global Market Development لمشروع برامج علم الجينوم السكاني في شركة Illumina، حيث أضاف إلى خبرته السابقة كمدير لإشراك الصناعة ثم شغل منصب المدير التنفيذي لبرنامج Genomics Enterprises في شركة Genomics England. وقبل ذلك، شغل Simon عددًا من الأدوار الوظيفية العليا في الشركات الناشئة، والشركات الاستشارية والشركات الكبيرة عبر قطاعات متعددة.

تم تعيين Christian Bourne في منصب كبير نائبي الرئيس العالمي لعمليات المختبر Lab Operations بعد مرور سبع سنوات على عمله في شركة Illumina، حيث كان له دور فعال في إنشاء المختبر الحاصل على شهادة الاعتماد ISO:15189 الذي حقق نجاحًا كبيرًا في تنفيذ مشروع 100000 جينوم لبرنامج شركة Genomics England ــ لكي تبدأ الاستفادة من هذه التجربة في العديد من البرامج الأخرى في مختلف أنحاء العالم. وقبل ذلك، عمل Christian في بيئات المختبرات الأساسية والتسلسل الجينومي عالية الإنتاجية في مركز البحوث الجينومية Centre for Genomic Research في جامعة ليفربول، وشركتَي Cancer Research UK، وAstraZeneca، ووزارة البيئة والأغذية والشؤون الريفية (DEFRA) في المملكة المتحدة.

نبذة عن شركة Dante Labs

إنَّ Dante Labs هي شركة بيانات جينومية عالمية تختص ببناء فئة جديدة من تطبيقات الصحة التحويلية وطول العمر تستند إلى تسلسل الجينوم الكامل والذكاء الاصطناعي. تتضمن أصولنا واحدة من أكبر قواعد البيانات الجينومية التي تم جمعها بموجب موافقات على إجراء الدراسات البحثية، ومنصة برمجيات مسجلة الملكية مصممة لإطلاق العنان لقوة البيانات الجينومية على نطاق واسع، وعمليات مسجلة الملكية تتيح لنا اتباع نهج صناعي في التسلسل الجيني.

يقع مقر شركة Dante Labs في كامبريدج في المملكة المتحدة، ولها مختبر بحثي في مدينة ولفرهامبتون، وقد دعمت الشركةُ طلب حكومة المملكة المتحدة المُلحّ والعاجل لتوسيع نطاق حل الاختبارات عالية السعة والمؤتمتة للغاية لفيروس كورونا المستجد (كوفيد-19)، لتشمل المرضى المصابين فضلاً عن المرضى الذين يحملون أجسامًا مضادة لهذا الفيروس. وقد تمكَّنت شركة Dante Labs من تحقيق ذلك عن طريق الاستفادة من التكنولوجيا الحالية التي تم تطويرها لأبحاث تسلسل الجينوم الكامل.

Giorgio Lodi, giorgio.lodi@dantelabs.com. ‎+39 0862 191 0671

May 11, 2021

Dante Labs announces appointments of Paul Jones, Simon Partridge and Christian Bourne to turbo-charge global population genomics programmes

Paul Jones, Simon Partridge and Christian Bourne, previously from Illumina and Genomics England, have joined Dante Labs in its new Cambridge, UK office to spearhead its ground-breaking global population genomics offer

CAMBRIDGE, United Kingdom, May 11, 2021 (GLOBE NEWSWIRE) — Dante Labs today announced Paul Jones, Simon Partridge and Christian Bourne have joined the Company’s Executive Team as part of its mission to enable faster, more effective population genomics programmes globally.

“We are excited to welcome Paul, Simon, and Christian to our team,” said Andrea Riposati, Chief Executive Officer of Dante Labs. “We share the vision for innovative solutions to accelerate the adoption of population genomics and precision medicine initiatives by healthcare systems and governments worldwide.”

The trio will drive Dante Labs’ clinical, research, industry engagement and economic development agendas for large-scale national programmes around the world. Jones, Partridge and Bourne were all formerly part of the population genomics team at S&P 500 company Illumina, and were involved in the development and acceleration of Genomics England, now considered the global benchmark programme for population genomics.

Paul Jones joins Dante Labs as Chief Business Officer. Paul brings 30 years of life sciences, technology, and healthcare experience to the organisation. Most recently, he was the Global Head of Population Genomics at Illumina where he led a team that created, developed and actively managed large-scale population genomics programmes across the world. Previously, Paul was CEO of Genomics Enterprises at Genomics England and Leader of Global Life Sciences at Cisco. He has also held senior positions at IMS Health, Novartis, and PwC Consulting.

Simon Partridge joins Dante Labs as VP, Global Head of Business Operations. He was most recently Global Market Development Lead for Population Genomics at Illumina, building upon past experience as Director of Industry Engagement and then Acting CEO of Genomics Enterprises at Genomics England. Prior to that Simon held several senior operational roles with start-ups, consultancies and large corporations across multiple sectors.

Christian Bourne has been appointed as Senior Director, Global Head of Lab Operations after seven years at Illumina, where he was instrumental in creating the highly successful ISO:15189 accredited lab that delivered the 100,000 genomes for the Genomics England programme – going on to utilise this experience with many other programmes around the world. Prior to this, Christian worked in high throughput genomic sequencing and core lab environments at The Centre for Genomic Research, the University of Liverpool, Cancer Research UK, AstraZeneca and DEFRA.

About Dante Labs

Dante Labs is a global genomic data company building and commercialising a new class of transformative health and longevity applications based on whole genome sequencing and AI. Our assets include one of the largest private genome databases with research consent, a proprietary software platform designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Headquartered in Cambridge, United Kingdom, with a research laboratory in Wolverhampton, Dante Labs supported the UK Government’s urgent requirement to scale-up a high-capacity, highly automated testing solution for Covid-19, including infected patients as well as those with antibodies. Dante Labs was able to deliver by leveraging existing technology that had been developed for whole genome sequencing.

Giorgio Lodi, giorgio.lodi@dantelabs.com. +39 0862 191 0671

May 11, 2021

GWM Listed Among 2021 BrandZ™ Top 50 Chinese Global Brand Builders for the First Time

BAODING, China, May 11, 2021 /PRNewswire/ — On May 10, Google and Kantar jointly released the “2021 BrandZ™ Top 50 Chinese Global Brand Builders”, and GWM was listed among other brands for the first time. Meanwhile, GWM was also listed among “2021 BrandZ™ Top 20 Rising Stars”. GWM has once again drawn the attention of global users with its manufacturing strength and steady growth after Auto Shanghai 2021.

BrandZ™ is an international and authoritative large brand building platform and the one and only brand value list that take consumers’ opinions into account. Since 2017, Google had joined with Kantar to collect data on the Google research platform and assess the growth of Chinese Global Brands with the globally recognized BrandZ™ brand value model developed by Kantar and based on the search volume on Google. The “2021 BrandZ™ Top 50 Chinese Global Brand” was released by Kantar along with Google. The research covered more than 860,000 consumers from 11 market places. The Top 50 list was based on scores of the significance, differentiation and high-lighting, and was selected from 1,662 candidates in 15 categories. According to IMF, the global economy has dropped by 3.5% due to the pandemic. However, many Chinese brands including GWM have shown the resolution to promote the brand establishment and boost overseas business growth facing the “black swan” incident.

In the last month, GWM has officially launched five brands at Auto Shanghai 2021, i.e. HAVAL, WEY, ORA, Pickup, and TANK in order to steadily promote their global expansion. As the major brand under the SUV category of GWM, HAVAL had won the first place among automobile brands on the 2020 “BrandZ™ Top 50 Chinese Global Brand”. In the first half of 2021, JOLION and 3rd Gen HAVAL H6 have been launched successively in core markets such as Saudi Arabia, Australia and South Africa. While the previously launched GWM POER has become the first Chinese pickup brand entering several countries. With overall layout in the global market, GWM will certainly solidify its leadership in the industry.

As one of the BrandZ™ Top 50 Chinese Global Brand Builders, GWM has formed its global sales network in major markets such as the Middle East, South America, Australia, South Africa and Russia, comprising more than 500 distributors. Its overseas sales cover more than 60 countries around the world. In the next five years, GWM will invest more than RMB 30 billion in global R&D and introduce more than 400 global automotive engineers and IT experts. Meanwhile, it will cooperate with global tech giants including Intel, Google and Apple to develop the most super-advanced technologies, and provide global users with more intelligent, high-tech and high-quality products.

Photo – https://mma.prnewswire.com/media/1507581/image.jpg

May 11, 2021

Zhang Yuzhuo, Chairman of Sinopec: Accelerating the World-class Brand Build up to Better Lead the High-quality Development of Enterprise

BEIJING, May 11, 2021 /PRNewswire/ — The “2021 China Brand Value Evaluation Information” released on May 9 amid the Fifth China Brand Day celebration, China Petroleum & Chemical Corporation (HKG: 0386, “Sinopec”) ranks No.1 across the energy and chemical industry in China with a brand value of 308.59 billion yuan ($48.01 billion), a 9.491 billion yuan ($1.48 billion) growth compare to 2020. Brands value of its Easy Joy, Epec.com, Sinopec Lubricant Company, and Sinopec Donghai Asphalt raised significantly.

At the forum on China Corporate Brand Building held on May 10, Mr. Zhang Yuzhuo’s keynote speech solemnly stated that Sinopec will accelerate to build a world-class independent brand to better lead the high-quality development of the enterprise.

Manufacturing capacity in China continues to grow and develop, showing vigorous vitality and creativity with increased number of Chinese brands going abroad.

For 38 years, Sinopec has emphasized on strengthening brand building and committed to bring the society cleaner, higher-end and more diverse energy and chemical products. Fulfilled its brand promises with actions and responsibilities, Sinopec will continue to meet people’s needs for better life and promote the company’s brand value, reputation and influence.

“Sinopec will step up in building a world-class brand, adhering to the brand value proposition of ‘Innovation leads the future of the industry, creating better life with responsibility,” as well as making the brand slogan of ‘Cleaner Energy, Better Life’ deeply rooted in customers’ hearts, entering thousands upon thousands of households as a responsible international enterprise,” said Zhang Yuzhuo, chairman of Sinopec.

Sinopec Hydrogen Refueling Station Is in Use in China with another 100 Stations Planned to Build and Operate in 2021.

In the future, Sinopec will Implement the brand strategy vigorously and firmly establish the concept of “quality is always one step ahead” and “every drop of oil is a promise” to highlight Sinopec’s commitment to quality first, speeding up the promotion of brand vitality. Guided by the implementation of a world-leading development strategy, Sinopec will strengthen its operation management and speed up to improve brand support.

By taking the opportunity of building a pioneering technology company, Sinopec will also continue to innovate and boost its brand competitiveness, along with speed up the green and low-carbon transition, promoting clean fossil energy, scaled non-fossil energy and low-carbon production process to ensure that it reaches the carbon emissions peak before China’s goal and strives to achieve carbon neutral by 2050.

In addition, Sinopec will support key projects of rural revitalization, Beijing 2022 Winter Olympics, health express initiative, public open days, charity gas stations for sanitation workers and more to consolidate social responsibility and elevate brand influence, making “responsible” a keyword of the Sinopec brand.

About Sinopec

Sinopec Corp. is one of the largest integrated energy and chemical companies in China. Its principal operations include the exploration and production, pipeline transportation and sale of petroleum and natural gas; the sale, storage and transportation of petroleum products, petrochemical products, coal chemical products, synthetic fiber, fertilizer and other chemical products; the import and export, including an import and export agency business, of petroleum, natural gas, petroleum products, petrochemical and chemical products, and other commodities and technologies; and research, development and application of technologies and information.

Sinopec sets ‘fueling beautiful life’ as its corporate mission, puts ‘people, responsibility, integrity, precision, innovation and win-win’ as its corporate core values, pursues strategies of value-orientation, innovation-driven development, integrated resource allocation, open cooperation, and green and low-carbon growth, and strives to achieve its corporate vision of building a world leading energy and chemical company.

For more information, please visit: http://www.sinopecgroup.com/group/en/.

Photo – https://mma.prnewswire.com/media/1507602/image_1.jpg
Photo – https://mma.prnewswire.com/media/1507603/image_2.jpg
Logo – https://mma.prnewswire.com/media/960416/SINOPEC_Logo.jpg

May 11, 2021

Zymo Research Releases Open-Source Bioinformatics Pipeline for SARS-CoV-2 Variant Detection in Wastewater

Early Release of the VirSieve^™ Bioinformatics Pipeline Will Promote Collaboration in Environmental SARS-CoV-2 Research

IRVINE, Calif., May 11, 2021 /PRNewswire/ — Zymo Research has released the VirSieve^™ Bioinformatics Pipeline source code to the environmental microbiology community to promote global collaboration and support for the detection of SARS-CoV-2 variants in wastewater. VirSieve^™ is an automated computational pipeline that analyzes sequencing reads from the SARS-CoV-2 virus in wastewater samples to better understand viral variants present in monitored communities. By rating the confidence interval in observed viral mutations, the software has the potential to significantly increase the accuracy of analyzing any changes in the viral genetic material.

Zymo Research releases the VirSieve™ Open-Source Bioinformatics Pipeline source code to the environmental microbiology community to promote global collaboration and support for the detection of SARS-CoV-2 variants in wastewater.

According to the Centers for Disease Control and Prevention, while the deployment of vaccines has had a tremendous positive impact on curbing the SARS-CoV-2 pandemic within the USA, new viral strains are still emerging. Some of these strains, e.g., B.1.1.7, are classified as “variants of concern” due to evidence of increased spread, pathogenicity, or vaccine evasion. Wastewater Next-Gen Sequencing is emerging as the most viable solution for near real-time community surveillance.

Viral sequencing from wastewater is difficult due to fragmentation and degradation of the viral RNA, often resulting in sequencing errors that ultimately manifest as false mutations. VirSieve^™ can identify these false variants and mark them as being low or no confidence, allowing researchers to filter mutations with a higher degree of support. Zymo Research also provides DNA/RNA Shield^™, a reagent that safeguards viral RNA from further degradation after inactivation of any virus for safe, ambient temperature collection and transportation of wastewater samples.

“Zymo Research has previously developed public software tools like the Zymo Research Transmit Program, an open-source client for submitting COVID-19 test results through the CalREDIE public health reporting system,” said Dr. Michael Weinstein, Director of Laboratory Information Systems, and Project Lead on the VirSieve^™ Pipeline project at Zymo Research. “VirSieve^™ is part of Zymo Research’s ongoing effort to provide maximum support to pandemic response efforts around the globe. We feel VirSieve^™ has the potential to be used not only for tracking variant strains of the SARS-CoV-2 virus in wastewater but other viruses as well, for future public health efforts.”

“Getting accurate variants from clinical samples or sewage is key to proper placement of a viral strain in the context of all other viral variants and informing pathogen tracking efforts,” said Dr. Christopher Mason, who is a paid speaker for Zymo Research and is the co-director of the WorldQuant Institute for Quantitative Prediction and a professor of physiology and biophysics at Weill Cornell Medicine.

For more information about the VirSieve^™ Pipeline visit Zymo Research’s website or contact them via email at tech@zymoresearch.com.

About Zymo Research Corp.
Zymo Research is a privately owned company that has been serving the scientific and diagnostics community with state-of-the-art molecular biology tools since 1994. “The Beauty of Science is to Make Things Simple” is their motto, which is reflected in all of their products, from epigenetics to DNA/RNA purification technologies. Historically recognized as the leader in epigenetics, Zymo Research is breaking boundaries with novel solutions for sample collection, microbiomic measurements, diagnostic devices, and NGS technologies that are high quality and simple to use. Follow Zymo Research on Facebook, LinkedIn, Twitter, and Instagram.

For more information about Zymo Research’s COVID-19 products, check out the following links:

Photo – https://mma.prnewswire.com/media/1507133/Wastewater_PR_data_on_computer_2000x1111px.jpg
Logo – https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg